Search - tctmd.com

Displaying 281 - 300 of 1464

Sort: Relevancy | Date

News Conference News ACC 2023

Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT

Yael L. Maxwell

March 07, 2023

News Conference News ACC 2023

Free Meds Don’t Reduce CV Events, but Tailored Messaging Does: ACCESS

Caitlin E. Cox

March 05, 2023

For Complex PCI, Intravascular Imaging Lowers Risk of Target Vessel Failure

News Conference News ACC 2023

For Complex PCI, Intravascular Imaging Lowers Risk of TVF

Michael O'Riordan

March 05, 2023

Presentation ACC 2023

A Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease (PCDS Statin)

Presenter: Salim Virani

March 05, 2023

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

News Conference News ACC 2023

STOP-CA: Atorvastatin Curbs Heart Function Decline During Chemotherapy

L.A. McKeown

March 04, 2023

News Conference News ACC 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Michael O'Riordan

March 04, 2023

News Conference News ACC 2023

By Mid-Century, More Hot Days Will Spur More CV Deaths

Caitlin E. Cox

March 02, 2023

News Daily News

Don’t Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC

Michael O'Riordan

March 01, 2023

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

L.A. McKeown

February 13, 2023

News Daily News

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

L.A. McKeown

February 02, 2023

News Daily News

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Michael O'Riordan

January 20, 2023

News Daily News

Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis

Todd Neale

January 20, 2023

News Daily News

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

Yael L. Maxwell

January 17, 2023

News Daily News

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Michael O'Riordan

January 16, 2023

News Daily News

CT Angiography Is Increasing in England, but Downstream Tests Are Not

Michael O'Riordan

January 12, 2023

News Daily News

Exercise Intensity, Not Volume, Linked to Atherosclerosis Progression in Men

Michael O'Riordan

January 10, 2023

News Daily News

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Michael O'Riordan

January 05, 2023

Advertisement

Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT

Free Meds Don’t Reduce CV Events, but Tailored Messaging Does: ACCESS

For Complex PCI, Intravascular Imaging Lowers Risk of TVF

A Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease (PCDS Statin)

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

STOP-CA: Atorvastatin Curbs Heart Function Decline During Chemotherapy

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

By Mid-Century, More Hot Days Will Spur More CV Deaths

Don’t Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC

What’s Going to Be Hot at ACC/WCC 2023?

Only Half of Revascularized PAD Patients Receive GDMT

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

CT Angiography Is Increasing in England, but Downstream Tests Are Not

Exercise Intensity, Not Volume, Linked to Atherosclerosis Progression in Men

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content